Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Inhibitex Starts Veronate Hospital Infection Phase III Trial In Infants

July 1, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Taste Technology Firm Senomyx Goes Public With $36M Offering

June 23, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 10, 2025
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...
Australia’s Celosia heads toward clinic with gene therapy for ALS
BioWorld
After raising AU$16.75 million (US$10.4 million) in a series A round, Celosia Therapeutics Pty Ltd. is heading toward the clinic with its novel gene therapy that...
Sangamo stock plunges as Pfizer leaves hemophilia partnership
BioWorld
Sangamo Therapeutics Inc.’s stock sank sharply on the last day of 2025 as Pfizer Inc. handed back the rights to their collaborative gene therapy hemophilia A...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.